Logo image of NUKK

NUKKLEUS INC (NUKK) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:NUKK - US67054R2031 - Common Stock

6.3 USD
-0.16 (-2.48%)
Last: 12/8/2025, 11:11:36 AM
Fundamental Rating

0

Overall NUKK gets a fundamental rating of 0 out of 10. We evaluated NUKK against 280 industry peers in the Software industry. Both the profitability and financial health of NUKK have multiple concerns. NUKK is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

NUKK had negative earnings in the past year.
In the past year NUKK has reported a negative cash flow from operations.
In the past 5 years NUKK always reported negative net income.
NUKK had a negative operating cash flow in each of the past 5 years.
NUKK Yearly Net Income VS EBIT VS OCF VS FCFNUKK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -2M -4M -6M -8M

1.2 Ratios

The Return On Assets of NUKK (-119.19%) is worse than 93.57% of its industry peers.
Industry RankSector Rank
ROA -119.19%
ROE N/A
ROIC N/A
ROA(3y)-293.97%
ROA(5y)-177.05%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NUKK Yearly ROA, ROE, ROICNUKK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200 -200 -400 -600 -800

1.3 Margins

NUKK does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NUKK Yearly Profit, Operating, Gross MarginsNUKK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

More info and screens

1

2. Health

2.1 Basic Checks

Compared to 1 year ago, NUKK has more shares outstanding
NUKK has less shares outstanding than it did 5 years ago.
NUKK has a better debt/assets ratio than last year.
NUKK Yearly Shares OutstandingNUKK Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
NUKK Yearly Total Debt VS Total AssetsNUKK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M

2.2 Solvency

Based on the Altman-Z score of -29.64, we must say that NUKK is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of NUKK (-29.64) is worse than 94.29% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -29.64
ROIC/WACCN/A
WACCN/A
NUKK Yearly LT Debt VS Equity VS FCFNUKK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -50M -100M -150M

2.3 Liquidity

A Current Ratio of 0.12 indicates that NUKK may have some problems paying its short term obligations.
The Current ratio of NUKK (0.12) is worse than 97.50% of its industry peers.
A Quick Ratio of 0.12 indicates that NUKK may have some problems paying its short term obligations.
NUKK has a worse Quick ratio (0.12) than 97.50% of its industry peers.
Industry RankSector Rank
Current Ratio 0.12
Quick Ratio 0.12
NUKK Yearly Current Assets VS Current LiabilitesNUKK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

More info and screens

0

3. Growth

3.1 Past

NUKK shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -3199.80%.
EPS 1Y (TTM)-3199.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%158.78%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-100%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NUKK Yearly Revenue VS EstimatesNUKK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 5M 10M 15M 20M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

NUKK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NUKK Price Earnings VS Forward Price EarningsNUKK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NUKK Per share dataNUKK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share -1 -2 -3 -4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for NUKK!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NUKKLEUS INC

NASDAQ:NUKK (12/8/2025, 11:11:36 AM)

6.3

-0.16 (-2.48%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-17 2025-11-17
Earnings (Next)02-02 2026-02-02
Inst Owners4.33%
Inst Owner Change235.86%
Ins Owners11.93%
Ins Owner Change0.4%
Market Cap104.89M
Revenue(TTM)N/A
Net Income(TTM)-8.52M
AnalystsN/A
Price TargetN/A
Short Float %10.57%
Short Ratio0.68
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-4.92
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.32
FCFYN/A
OCF(TTM)-0.23
OCFYN/A
SpS0
BVpS-3.21
TBVpS-3.21
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -119.19%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-293.97%
ROA(5y)-177.05%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 30916.3%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.12
Quick Ratio 0.12
Altman-Z -29.64
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-3199.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%158.78%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-100%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-458.33%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-414.52%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-321.05%
OCF growth 3YN/A
OCF growth 5YN/A

NUKKLEUS INC / NUKK FAQ

What is the fundamental rating for NUKK stock?

ChartMill assigns a fundamental rating of 0 / 10 to NUKK.


Can you provide the valuation status for NUKKLEUS INC?

ChartMill assigns a valuation rating of 0 / 10 to NUKKLEUS INC (NUKK). This can be considered as Overvalued.


What is the profitability of NUKK stock?

NUKKLEUS INC (NUKK) has a profitability rating of 0 / 10.


How financially healthy is NUKKLEUS INC?

The financial health rating of NUKKLEUS INC (NUKK) is 1 / 10.